Filing Details
- Accession Number:
- 0001209191-23-035618
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-09 08:00:14
- Reporting Period:
- 2023-06-08
- Accepted Time:
- 2023-06-09 08:00:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1658247 | Crinetics Pharmaceuticals Inc. | CRNX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1610381 | Rogerio Coelho Vivaldi | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-08 | 5,000 | $22.06 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $22.06 per share. The range of actual purchase prices on the transaction date was $22.02 to $22.08 per share. Detailed information on the exact number of shares purchased at each price can be obtained from the issuer upon request.